TABLE 2

Characteristics of the international primary ciliary dyskinesia cohort (iPCD Cohort)

CountryPrincipal investigatorPatients nAge range years#Males %Type of data deliveredData richness
ArgentinaS. Scigliano1016–5742Cross-sectionalIntermediate
AustraliaL. Morgan1090–7660LongitudinalHigh
BelgiumM. Boon820–6945Cross-sectionalHigh
CyprusP. Yiallouros310–6648LongitudinalHigh
DenmarkK.G. Nielsen1200–7048LongitudinalIntermediate
FranceA. Clement3370–6952LongitudinalHigh
Germany (Bochum)C. Koerner-Rettberg640–2740Cross-sectionalHigh
Germany (Muenster)H. Omran4363–7552Cross-sectionalBasic
Germany (Hannover)N. Schwerk370–3968LongitudinalHigh
IsraelI. Amirav2100–6056Cross-sectionalHigh
ItalyItalian PCD group3310–7350Cross-sectionalIntermediate
The NetherlandsE. Haarman823–6950LongitudinalIntermediate
NorwayS. Crowley230–1865LongitudinalHigh
PolandH. Mazurek1051–2256Cross-sectionalHigh
SerbiaZ. Zivkovic106–1945LongitudinalHigh
SwitzerlandSwiss PCD group1083–7051LongitudinalHigh
TurkeyB. Karadag373–2143Cross-sectionalIntermediate
UK (Paediatric Pulmonology Dept, Brompton)C. Hogg1161–1847Cross-sectionalBasic
UK (Adult Pulmonology Dept, Brompton)M. Loebinger15220–7638Cross-sectionalBasic
UK (Southampton)J. Lucas1040–6849LongitudinalIntermediate
USA/CanadaGenetic Diseases of Mucociliary Clearance Consortium4180–7744Cross-sectionalBasic
iPCD Cohort30130–7750
  • #: at time of data delivery; : semiquantitative measure based on the number of delivered variables.